Join us for Cleveland Clinic’s Global EP 2024.
Join the world’s leading EP experts for this 2-day symposium where they will discuss innovations in devices, techniques, recent clinical trials and current guidelines in cardiac electrophysiology. Topics include ablation for atrial fibrillation, stroke prevention in atrial fibrillation, methods for mapping of ventricular arrhythmias, new frontiers in pacing and lead management, and sudden cardiac death and CHD. This meeting will provide attendees with a thorough and practical course on the current state of the art in the field and provide an opportunity for both faculty and attendees to interact in a forum which will encourage an open discussion of arrhythmia management, perceived challenges and future directions.
After completing this activity, participants will be able to:
- Apply recent evidence and current guideline recommendations to the management of all types of cardiac arrhythmias.
- Provide a current review of new information on the clinical science, pathophysiology and risk factors for atrial fibrillation and atrial fibrillation-related stroke.
- Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease including new ablation techniques and technologies.
- Summarize the current status and future role for device therapy in the management of sudden cardiac death and heart failure.
- Integrate and evaluate emerging evidence and new technologies for the prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation.
- Demonstrate awareness of cardiac implantable electronic devices, allowing greater ability to address questions, problems, and other issues related to CIEDs in their patients.
- Integrate preparation, recognition and avoidance of device and ablation complications.
- Evaluate up-to-date management of arrhythmias in special populations, including in athletes and older adults.